Glass House Brands Inc. GLAS
Medicinal Chemicals and Botanical Products · data as of November 13, 2026
Glass House Brands Inc. (GLAS) is a healthcare company listed in the US with a market value of about $112M. In the twelve months to June 30, 2026 it had revenue of $177M and net income of -$68M, a net margin of -38.2%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 30% a year, a 5-year average ROIC of -13%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 12% below the current price.
About Glass House Brands
Glass House Brands is listed in the US and classified in medicinal chemicals and botanical products. Revenue went from $48M in 2020 to $182M in 2025, growth of about 30.4% a year. It was profitable in 1 of the last 6 years in our data.
Score: 0.8 / 5
Checks passed
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year revenue growth above 8% a year
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $177M | $182M | $201M | $161M | $85M | $63M | $48M |
| Net income | -$68M | -$30M | $519000 | -$98M | -$33M | -$43M | -$17M |
| Free cash flow | -$37M | -$16M | $18M | $11M | -$69M | -$129M | -$12M |
| EPS (diluted) | $-0.79 | $-0.34 | $0.01 | $-1.12 | $-0.37 | $-0.49 | $-0.19 |
| Net margin | -38.2% | -16.3% | 0.3% | -61.1% | -38.8% | -68.2% | -34.5% |
| ROIC | — | -8.9% | 2.5% | -24.0% | -20.5% | -12.4% | -10.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 3 analysts is $9.00, 609% above the current price; targets range from $7.00 to $12.00; the consensus rating is “none”; expected EPS is $-0.50 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Glass House Brands stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 12% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Glass House Brands pay a dividend?
Not currently.
Is Glass House Brands a good stock to buy?
We do not give buy or sell advice. Glass House Brands scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.